These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7891051)

  • 1. Diagnosis of acute intermittent porphyria in northern Sweden: an evaluation of mutation analysis and biochemical methods.
    Andersson C; Thunell S; Floderus Y; Forsell C; Lundin G; Anvret M; Lannfelt L; Wetterberg L; Lithner F
    J Intern Med; 1995 Mar; 237(3):301-8. PubMed ID: 7891051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients.
    Schuurmans MM; Schneider-Yin X; Rüfenacht UB; Schnyder C; Minder CE; Puy H; Deybach JC; Minder EI
    Mol Med; 2001 Aug; 7(8):535-42. PubMed ID: 11591889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphobilinogen deaminase gene mutations in Polish patients with non-erythroid acute intermittent porphyria.
    Szlendak U; Lipniacka A; Bianketti J; Podolak-Dawidziak M; Bykowska K
    Adv Clin Exp Med; 2015; 24(1):63-8. PubMed ID: 25923088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and evaluation of two porphobilinogen deaminase activity assays for diagnosis of acute intermittent porphyria.
    Lin CN; Huang YC; Ro LS; Liao MF; Ning HC; Kuo HC
    Clin Chim Acta; 2018 Apr; 479():1-6. PubMed ID: 29317194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A family of acute intermittent porphyria].
    Igarashi M; Daimon M; Usuki K; Hirai Y; Nakahara F; Iijima K; Iki S; Kondo M; Kato T; Urabe A
    Rinsho Ketsueki; 2004 Jul; 45(7):562-7. PubMed ID: 15359917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families.
    Kauppinen R; von und zu Fraunberg M
    Clin Chem; 2002 Nov; 48(11):1891-900. PubMed ID: 12406973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porphobilinogen deaminase gene structure and molecular defects.
    Deybach JC; Puy H
    J Bioenerg Biomembr; 1995 Apr; 27(2):197-205. PubMed ID: 7592566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for an ancestral founder of the common R116W mutation in the hydroxymethylbilane synthase gene in acute intermittent porphyria in The Netherlands.
    de Rooij FW; Kavelaars FG; Koole-Lesuis H; Wilson JH
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):64-9. PubMed ID: 19656453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic strategy, genetic diagnosis and identification of new mutations in intermittent porphyria by denaturing gradient gel electrophoresis.
    Nissen H; Petersen NE; Mustajoki S; Hansen TS; Mustajoki P; Kauppinen R; Hørder M
    Hum Mutat; 1997; 9(2):122-30. PubMed ID: 9067752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene.
    Kauppinen R; Mustajoki S; Pihlaja H; Peltonen L; Mustajoki P
    Hum Mol Genet; 1995 Feb; 4(2):215-22. PubMed ID: 7757070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden.
    Innala E; Andersson C
    J Intern Med; 2011 May; 269(5):538-45. PubMed ID: 21198994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A point mutation, C to T, in exon 8 of the porphobilinogen deaminase gene in a Japanese family with acute intermittent porphyria.
    Morita Y; Daimon M; Kashiwaba M; Yamatani K; Igarashi M; Fukase N; Ohnuma H; Ikezawa Y; Sugiyama K; Manaka H
    Jpn J Hum Genet; 1995 Jun; 40(2):207-13. PubMed ID: 7663002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic investigation of the porphobilinogen deaminase gene in Swedish acute intermittent porphyria families.
    Lundin G; Lee JS; Thunell S; Anvret M
    Hum Genet; 1997 Jul; 100(1):63-6. PubMed ID: 9225970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation in a family with non-erythroid variant form of acute intermittent porphyria.
    Yu S; Poulos V; Stewart P
    J Hum Genet; 2000; 45(6):367-9. PubMed ID: 11185747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular genetic study of acute intermittent porphyria in Russia: mutation analysis and functional polymorphism search in porphobilinogen deaminase gene].
    Surin VL; Luchinina IuA; Selivanova DS; Pustovoĭt IaS; Karpova IS; Pivnik AV; Luk'ianenko AV; Kravchenko SK
    Genetika; 2010 Apr; 46(4):540-52. PubMed ID: 20536026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exon 1 donor splice site mutations in the porphobilinogen deaminase gene in the non-erythroid variant form of acute intermittent porphyria.
    Puy H; Gross U; Deybach JC; Robréau AM; Frank M; Nordmann Y; Doss M
    Hum Genet; 1998 Nov; 103(5):570-5. PubMed ID: 9860299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene.
    Floderus Y; Shoolingin-Jordan PM; Harper P
    Clin Genet; 2002 Oct; 62(4):288-97. PubMed ID: 12372055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular study of the hydroxymethylbilane synthase gene (HMBS) among Polish patients with acute intermittent porphyria.
    Gregor A; Schneider-Yin X; Szlendak U; Wettstein A; Lipniacka A; Rüfenacht UB; Minder EI
    Hum Mutat; 2002 Mar; 19(3):310. PubMed ID: 11857754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An odd case of heteroallelic acute intermittent porphyria in the Argentinean population.
    Piñeiro Pauwels MB; Gerez EN; Martinez MC; Melito VA; Parera VE; Batlle A; Rossetti MV
    Cell Mol Biol (Noisy-le-grand); 2013 Mar; 59 Suppl():OL1855-60. PubMed ID: 23522335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study.
    Andersson C; Floderus Y; Wikberg A; Lithner F
    Scand J Clin Lab Invest; 2000 Nov; 60(7):643-8. PubMed ID: 11202057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.